NEW: Medvi -- the compounded drug marketer featured in *that* NYT profile -- issued a statement yesterday in response to public scrutiny over dishonest marketing tactics (fake doctors, fake patients) and an FDA warning.

We have (more) questions.

futurism.com/artificial-intelligence/ai-drug-marketer-medvi-responds

April 09, 2026 - 22:34 UTC

1
2
52
For more context about Medvi, the initial article, and what it was missing -- though the NYT did update the piece today with more info about Medvi's regulatory/legal troubles -- see this thread:

bsky.app/profile/mharrisondupre.bsky.social/post/3mitok43pkc2c
1
0
8
Medvi's "response to external speculation," published yesterday, focuses heavily on the FDA warning it received in Feb 2026 regarding multiple violations on the website Medvi(.io.)

It's true that Medvi was one of several similar companies to receive a warning amid a broader FDA crackdown...
1
0
6